Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,420,629
+$322,088 QoQ
Shares Held
33,156
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
#1,212
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sargent Investment Group, LLC holds $34,963,451 across 9 Drug Manufacturers - General names. JNJ ranks #2 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
46,728 | $11,758,633 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
33,156 | $8,420,629 | |
| 3 | LLY |
ELI LILLY & Co
|
5,913 | $7,092,230 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,863 | $3,323,395 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
36,270 | $2,089,877 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,842 | $1,369,778 | |
| 7 | AMGN |
Amgen Inc
|
1,276 | $462,065 | |
| 8 | PFE |
Pfizer Inc
|
9,550 | $229,964 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,420,629 | 33,156 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $8,098,541 | 33,131 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,840,318 | 33,053 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,588,588 | 24,747 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,790,949 | 24,818 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,096,413 | 24,701 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $3,038,321 | 21,009 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $3,474,728 | 21,441 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $3,183,218 | 21,779 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,376,249 | 21,343 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,979,471 | 25,389 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $4,052,147 | 26,017 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,017,335 | 24,271 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $3,857,330 | 24,886 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $4,538,845 | 25,694 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $4,183,486 | 25,609 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $4,520,114 | 25,464 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $4,490,830 | 25,339 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $4,214,993 | 24,639 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,196,900 | 25,987 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,107,132 | 24,931 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $4,118,775 | 25,061 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $3,506,269 | 22,279 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,229,058 | 21,689 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,888,118 | 20,537 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,670,069 | 20,362 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||